Skip to content
AMR continues to pose a global threat
September was a big month for those following antimicrobial resistance (AMR). A new study highlighted the growing public health burden of AMR, and the […]
AMR continues to pose a global threat Read More »
Latest News
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents
Food and Drug Administration (FDA) inaction on patents for drug delivery devices has been troubling drug manufacturers for 20 years, and the situation is
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents Read More »
As Mexico changes presidents, House members urge action on corn ban
As Claudia Sheinbaum became Mexico’s president on Oct. 1, a bipartisan letter from 21 American Congress members called on U.S. officials to resolve the
As Mexico changes presidents, House members urge action on corn ban Read More »
BIO speaks on Capitol Hill about mpox preparedness
Mpox has proven to be a major public threat since its resurgence globally during the COVID years. As Bio.News reported, “On Aug. 14, the
BIO speaks on Capitol Hill about mpox preparedness Read More »
What to know about BIO’s 7 Core Strategic Priorities
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve policy that impacts the
What to know about BIO’s 7 Core Strategic Priorities Read More »
Driving a ‘patient-led revolution’: John F. Crowley at the Global Genes RARE Advocacy Summit
Going from “we have a problem” to “we have an idea” to “we have a solution” is an important journey for patient advocates and
Senate Sustainable Aviation Caucus to back pro-SAF legislation
Sustainable aviation fuel (SAF) uses the power of biology to launch airliners. A group of senators said they will use their legislative power to
Senate Sustainable Aviation Caucus to back pro-SAF legislation Read More »
Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security.
CMS listens to BIO and understands proposed policies could have harmed patients, innovation
A new suite of rules governing drug rebates in Medicaid has been finalized, removing months of uncertainty about whether the Centers for Medicare and
Sepsis Awareness Month: 3 things you need to know about sepsis
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »